A p r i l 2 2 , 2 0 1 0
SLIS J748, Spring 2010 - Dr. Kendra AlbrightBusinessReport - Pfizer Inc., prepared by Aileen Marshall
includes biologic and small molecule medicines, vaccines, nutritional products and manywell-known consumer products.
The latter include the erectile dysfunction treatmentViagra, pain management drugs Celebrex and Lyrica, depression management drug Zoloft,the popular ChapStick, cholesterol-lowering Lipitor, and more.
The company's maincompetitors include Bayer AG, Merck, Novartis, Proctor and Gamble, and Johnson & Johnson, among others.
Notable acquisitions and mergers include the purchase of the drug maker Roerig in1953, SmithKline Beecham's animal health business in 1995, Procter & Gamble's Bain deSoleil skin care line and Warner -Lambert in 1999, its rival Pharmacia in 2003 ($54 billion),the research division of QuoreX and Esperion Therapeutics in 2004, Vicuron Pharmaceuticalsin 2005 (which was divested again in 2009)
, and pharma rival Wyeth in a $68 billion deal in2009, making this the largest merger of pharmaceutical companies in nearly a decade.
There is also a rumor that Pfizer is seeking a buyer for its division of experimental drugs,which include over 100 drugs that treat conditions such as high cholesterol and obesity. Asof July 23, 2009 there has not been named an interested buyer to acquire this asset.
According to Hoover's, Pfizer made $50,009 million in sales in 2009. The followingtable summarizes the percentage of sales in different regions.
See Appendix B for a complete list of products.
TFSD Worldwide M&A (2010)